Get started

U-nyse

Pan American Silver (PAAS) AnalysisStrategic Portfolio Optimization: Pan American Silver NYSE:PAAS , a prominent global precious metal mining company, is bolstering its market position through strategic initiatives. Recently, PAAS agreed to sell its Lucita property to Defiance Silver and its La Arena gold property in Peru to Jinteng Mining for $245 million upfront, plus contingent payments. These moves align with PAAS's strategy to optimize its portfolio and strengthen its financial position. Leadership Insight: CEO Michael Steinmann highlighted the strategic benefits, stating, "With the sale of La Arena, we continue to optimize our portfolio while retaining future upside through royalties." Investment Outlook: Bullish Outlook: We are bullish on PAAS above the $16.50-$17.00 range. Upside Potential: With a target set at $28.00-$30.00, investors should consider PAAS's enhanced financial outlook and strategic portfolio optimization as key drivers for potential stock appreciation. 📊⚒️ Stay informed about Pan American Silver for promising investment opportunities! #PAAS #PreciousMetals 📈🔍
NYSE:PAASLong
by Richtv_official
DaVita (DVA) AnalysisLeading Dialysis Service Provider: DaVita NYSE:DVA stands as a top kidney dialysis service provider in the U.S., demonstrating strong resilience post-COVID-19. CEO Javier Rodriguez emphasized the company's strengthened position and continued investments in staff and systems. Expansive Market Potential: With 40 million Americans affected by kidney disease, the dialysis market is valued at an impressive $100 billion. DaVita, as a major player, serves a significant portion of the 786,000 people requiring dialysis or transplants annually. Financial Performance: DaVita boasts a robust financial performance with a remarkable 53% Return on Equity (ROE) over the past five years, indicating effective value creation and investor capital management. Investment Outlook: Bullish Outlook: We are bullish on DVA above the $125.00-$126.00 range. Upside Potential: With a target set at $195.00-$200.00, DaVita’s strong market position and impressive financial metrics suggest strong growth potential in this essential healthcare sector. 📊🩺 Stay tuned for promising investment opportunities with DaVita! #DVA #HealthcareServices 📈🔍
NYSE:DVALong
by Richtv_official
Trade Like A Sniper - Episode 25 - BABA - (8th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Alibaba (BABA), starting from the 6-Month chart. If you want to learn more, check out my other videos on TradingView or on YT. If you are interested in private coaching, feel free to get in touch via one of my socials.
NYSE:BABAEducation
by Road_2_Funded
Elanco Animal Health (ELAN) AnalysisMarket Position: Elanco Animal Health NYSE:ELAN focuses on innovating and marketing products for pets and farm animals. CEO Jeff Simmons credits the company's growth to "accelerating contribution from innovation, stabilizing core volumes, price growth, and improved market conditions in Europe." Sector Growth: Animal health is a promising sector for growth investors, driven by increasing pet ownership, with 70% of U.S. households now owning a pet, up from 56% in 1988. As a major player, Elanco stands to benefit significantly from this trend. Regulatory Approvals: Elanco recently received continued approval from the EPA and support from the FDA for its Seresto flea and tick collar for dogs and cats. This development opens a significant new revenue stream and is likely to drive the stock price higher. Investment Outlook: Bullish Outlook: We are bullish on ELAN above the $14.50-$15.00 range. Upside Potential: With a target set at $22.00-$23.00, investors should monitor Elanco’s innovations and market expansions, particularly with products like Seresto, to capitalize on the growing demand in animal healthcare. 📊🐾 Stay updated on Elanco Animal Health for promising investment opportunities! #ELAN #AnimalHealth 📈🔍
NYSE:ELANLong
by Richtv_official
Trade Like A Sniper - Episode 21 - INTC - (7th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Intel (INTC), starting from the 6-Month chart.
NASDAQ:INTCEducation
by Road_2_Funded
Trade Like A Sniper - Episode 19 - BRK.B - (6th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing the Berkshire Hathaway ETF chart, starting from the 6-Month chart.
NYSE:BRK.B
by Road_2_Funded
Trade Like A Sniper - Episode 17- Ford Motors - (5th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Ford Motors (F), starting from the 4-Month chart. - R2F
NYSE:F
by Road_2_Funded
Trade Like A Sniper - Episode 16 - Pfizer - (5th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing PFE (Pfizer), starting from the 4-Month chart. - R2F
NYSE:PFE
by Road_2_Funded
COSTCO 850 AFTER EARNIGS ?? 5 STRONG REASONS WHY !!! thanks to WWW.CAFECITYSTUDIO.COM NY RUNS GLOBAL INC . Robust Financials:Costco has consistently demonstrated strong financial performance. Its revenue growth, profitability, and debt management are impressive. The company’s ESG (Environmental, Social, and Governance) score for its industry is good, indicating responsible business practices . Customer Loyalty and Resilience:Costco’s loyal customer base contributes to its stability. Even during economic downturns, consumers tend to remain loyal to the brand. This loyalty makes Costco stock relatively recession-resistant, which is a valuable asset for long-term investors. Analyst Sentiment:Over the past few months, analysts have revised their average price target for Costco upwards significantly. This suggests positive sentiment and confidence in the company’s future prospects. There is high visibility into Costco’s activities for the coming years, supporting predictable sales. Inflationary Pressures:The recent inflationary pressures have positively impacted Costco stock. As the Federal Reserve adjusts its monetary policy, companies like Costco may benefit from higher prices and increased consumer spending. Valuation Considerations:While Costco’s fundamentals are strong, it’s essential to consider valuation. The company operates with relatively high earnings multiples. Investors should weigh the potential upside against the current valuation when projecting the stock price.
NASDAQ:COSTLong
by NYRUNSGLOBAL
🍔📈 Shake Shack (SHAK) Analysis 🌍🔍Strong Performance: Shake Shack NYSE:SHAK , a growing restaurant chain, ended 2023 on a high note with successful sales strategies and margin expansion. CEO Randy Garutti highlighted the opening of 41 new U.S. restaurants and 44 international locations, including in Thailand and the Bahamas. Despite inflationary pressures, same-store sales saw a 2.8% year-over-year increase. Expansion Potential: With the Federal Reserve potentially maintaining or lowering interest rates, Shake Shack could see further expansion in 2024. With 518 locations (334 in the U.S.) at the end of 2023, there is significant growth potential. While it may not reach the size of McDonald's, it could approach Five Guys' nearly 1,500 U.S. locations, potentially quadrupling its current count. Investment Outlook: Bullish Outlook: We are bullish on SHAK above the $87.00-$88.00 range. Upside Potential: With an upside target set at $145.00-$150.00, investors should monitor sales growth and expansion efforts as key performance drivers. 📊🍔 Keep a close watch on Shake Shack's growth for promising investment opportunities! #SHAK #RestaurantGrowth 🌍📈
NYSE:SHAKLong
by Richtv_official
👟💡 On Holding (ONON) Analysis 📈🔍Market Insights: On Holding NYSE:ONON , a global sports product developer, is demonstrating strong potential as it approaches a crucial resistance level within a bullish cup and handle formation, signaling possible substantial gains. Endorsements and Analyst Sentiment: The brand benefits from endorsements by high-profile athletes, including Roger Federer. Analysts like TD Cowen's John Kernan are bullish, with raised price targets and maintained buy ratings, indicating strong growth prospects. Expansion Plans: ONON's expansion into the Asia-Pacific market presents significant opportunities, with plans to open 100 new stores. The successful Cloudmonster franchise has driven robust sales, positioning ONON for further growth. Investment Outlook: Bullish Outlook: We are bullish on ONON above the $30.50-$31.00 range. Upside Potential: With an upside target set at $51.00-$52.00, investors should monitor technical patterns and earnings reports for confirmation of this growth potential. 📊👟 Keep a close watch on On Holding's performance for investment opportunities! #ONON #SportsProducts 📉🔍
NYSE:ONONLong
by Richtv_official